-The board has approved a strategic review of the biotech assets and ALT5 Sigma being the core focus going forward-
-The company is intending a name and stock symbol change to reflect this decision-
Read more at newswire.caAll information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
-The board has approved a strategic review of the biotech assets and ALT5 Sigma being the core focus going forward-
-The company is intending a name and stock symbol change to reflect this decision-
Read more at newswire.ca